Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Pigment Cell Melanoma Res. 2015 Feb 17;28(3):360–362. doi: 10.1111/pcmr.12356

Major Association of Vitiligo with HLA-A*02:01 in Japanese

Ying Jin 1,2, Masahiro Hayashi 1,4, Pamela R Fain 1,2,3, Tamio Suzuki 4, Kazuyoshi Fukai 5, Naoki Oiso 6, Atsushi Tanemura 5, Cherie L Holcomb 7, Melinda Rastrou 7, Henry A Erlich 7, Richard A Spritz 1,2
PMCID: PMC4397141  NIHMSID: NIHMS658869  PMID: 25645285

To the Editor,

Recently, genome-wide association studies (GWAS) have been particularly successful in identifying vitiligo susceptibility loci in populations of European-derived white, Chinese, and Indian subcontinental ancestry (Spritz, 2013). The strongest genetic associations of vitiligo are in the major histocompatibility complex (MHC) on chromosome 6, both in terms of statistical significance and magnitude of effect (odds ratio; OR). However, the specific associated MHC loci and alleles differ among different world populations. In European-derived whites, vitiligo is associated with both MHC class I (HLA-A) and class II loci. On the Indian subcontinent, vitiligo is associated with MHC class II loci. In Han Chinese, vitiligo is associated with the class III region (Spritz, 2013).

Here, we describe a detailed genetic association study of vitiligo with the MHC in the Japanese population. To test for association between vitiligo and the MHC region, we compared the allele frequencies of 1649 genotyped SNPs spanning the extended MHC in chr6p21.3 (chr6:25,895,575-33,421,577; de Bakker et al., 2006) in 177 Japanese vitiligo cases with those from 932 Japanese pseudocontrols, generated using data from the Japanese Single Nucleotide Polymorphism database (JSNP; http://snp.ims.u-tokyo.ac.jp/; Appendix S2). Genome-wide association analyses of this case-control dataset indicate minimal inflation of test statistics due to population stratification or other sources of bias (Appendix S1). As shown in Figure 1 and Table 1, we observed significant association of vitiligo with multiple SNPs in the MHC class I region; specifically, six SNPs located downstream of HLA-A (chr6:29,942,083-30,064,562). Most significant was rs9261394 (P = 4.49 × 10−5, OR = 1.60), while greatest OR was observed for rs3823375 (P = 5.91 ×10−5, OR = 1.67) (Table 1). There was no significant association of vitiligo with SNPs in the MHC class II or class III regions (Figure 1 and data not shown).

Figure 1.

Figure 1

Major histocompatibility complex association results for vitiligo in Japanese. Results of association of 1649 MHC region single-nucleotide polymorphisms (SNPs; black dots). SNPs are ordered by physical genomic position (GRCh37/hg19) versus −Log10(P value).

Table 1.

Most significant associations between 6 MHC class I region SNPs and vitiligo in Japanese

177 cases,
932 controls
Chromosome SNP Nucleotide Allele OR P-value1
6p21.3 rs3823355 29,942,083 T 1.64 9.22 × 10−5
rs6904029 29,943,067 A 1.64 9.22 × 10−5
rs3823375 29,944,158 C 1.67 5.91 × 10−5
rs9366752 30,024,677 T 1.65 8.02 × 10−5
rs6909253 30,055,643 G 1.57 8.45 × 10−5
rs9261394 30,064,562 A 1.60 4.49 × 10−5
1

P-values from the Cochran-Armitage trend test.

Corrrelation of HLA-A subtype

(http://www.inflammgen.org/index.php?ption=com_content&task=view&id=25&Itemid=42) and corresponding genotype (http://hapmap.ncbi.nlm.nih.gov/) data for rs3823375, the SNP with the greatest OR in the MHC class I region, for 44 Japanese controls showed that the rs3823375-C allele tags HLA-A*02 (r2 = 0.80, D’ = 1.0) (data not shown). To define the specific HLA-A*02 subtype associated with vitiligo in Japanese, we carried out next-generation DNA sequencing of HLA-A, HLA-B, and HLA-C exons 2, 3, and 4, which contain the sequence variations that define HLA subtypes (http://www.ebi.ac.uk/imgt/hla/). We sequenced 20 unrelated Japanese vitiligo patients selected on the basis of carrying the rs3823375 high-risk C allele: 11 homozygotes and 9 heterozygotes. As shown in Table S2, of the 22 HLA-A alleles among the 11 rs3823375-C homozygotes, 15 (68.2%) were HLA-A*02:01, 6 (27.3%) were HLA-A*02:06, and 1 (4.5%) was a non-HLA-A*02 allele. Similarly, among the rs3823375-C heterozygotes, 5 alleles were HLA-A*02:01, 3 were HLA-A*02:06, and the remainder were non-HLA-A*02; whereas phase in the heterozygotes is uncertain, assuming maximum parsimony this distribution is not different than among the homozygotes (P = 0.72). Thus, unlike in European-derived whites, in which the vitiligo-associated HLA-A region SNPs tag only HLA-A*02:01 (Jin et al., 2012), in Japanese the vitiligo-associated HLA-A region SNPs tags both HLA-A*02:01 and HLA-A*02:06, and also occasional non-HLA-A*02 alleles, but do not tag specific alleles of HLA-B or HLA-C (Table S2).

To determine whether HLA-A*02:01, HLA-A*02:06, or both, are associated with vitiligo in Japanese, we imputed genotypes for SNPs that specifically tag HLA-A*02:01 and HLA-A*02:06 in Japanese (de Bakker et al., 2006), using data from the 177 Japanese vitiligo cases and 89 Japanese controls from the 1000 Genomes Project (1KGP; (http://www.1000genomes.org/); imputation could not be performed for the JSNP control data used for the GWAS. Principal components analysis of genome-wide genotype data for these 266 subjects using EIGENSOFT (Price et al., 2006) identified one Japanese case as an outlier, which was therefore excluded. The remaining Japanese cases and controls matched well, with genomic inflation factor (Devlin et al., 2001) 1.018 based on genome-wide statistics for 428,762 autosomal SNPs (data not shown). The six MHC class I region SNPs that showed association with vitiligo in the initial comparison of 177 Japanese cases and 932 controls (Table 1) likewise showed association in the comparison of 176 Japanese cases and 89 controls (Table S3). HLA-A*02:01 is tagged (r2 = 1) by the T-A haplotype of SNPs rs9348834-rs6457110, whereas HLA-A*02:06 is tagged (r2 = 1) by the T-C haplotype of SNPs rs892666-rs2517699 (de Bakker et al., 2006). As shown in Table 2, the rs9348834-rs6457110 TA haplotype showed significant association with vitiligo (P = 4.26E-03, OR = 2.31), whereas the rs892666-rs2517699 TC haplotype showed no association (P =0.435, OR = 0.73). These results demonstrate that vitiligo is specifically associated with HLA-A*02:01 in Japanese.

Table 2.

Association analysis of haplotypes tagging HLA-A*02:01 and HLA-A*02:06 in 176 Japanese cases and 89 controls

Haplotypes defined by rs9348834 and rs6457110
Haplotype Frequency OR (95% CI) P-value1
CA 0.21 (−ref-) (−ref-)
TT 0.06 | |
CT 0.57 | |
TA (tags HLA-A*02:01) 0.16 2.31 (1.26-4.23) 4.26E-03
Haplotypes defined by rs892666 and rs2517699
Haplotype Frequency OR (95% CI) P-value1
CC 0.31 (−ref-) (−ref-)
CT 0.02 | |
TT 0.61 | |
TC (tags HLA-A*02:06) 0.06 0.73 (0.34-1.59) 4.35E-01

Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval.

1

P-value from the likelihood ratio test

Of the 177 Japanese vitiligo patients, 24 (13.6%) had other concomitant autoimmune diseases including autoimmune thyroid disease, rheumatoid arthritis, psoriasis, adult-onset autoimmune diabetes, and pernicious anemia (Table S1), as observed previously (Narita et al., 2011). To test whether association of vitiligo with the MHC class I region is direct, versus is indirectly driven by these other autoimmune diseases, we compared the case-control datasets of the 24 Japanese vitiligo patients with other autoimmune diseases versus the 153 patients without other diseases, both versus the 932 Japanese pseudocontrols, finding that only the vitiligo patients without other autoimmune diseases contributed to the significant P values of the 6 SNPs (data not shown). This indicates that association of vitiligo with the MHC class I region in Japanese is direct. In other analyses, we found no significant association of MHC class I region SNPs with vitiligo age of onset (Table S1) or gender (data not shown) in Japanese.

Our findings in Japanese vitiligo patients closely parallel those we have reported for the MHC class I region in European-derived white vitiligo patients, in whom MHC class I association derives from HLA-A; specifically, HLA-A*02:01 (Jin et al., 2010, 2012). HLA-A*02:01 presents peptide antigens on the surfaces of all cells. In melanocytes, HLA-A*02:01 presents the major vitiligo autoimmune antigen, tyrosinase (TYR), which in turn activates and recruits anti-melanocyte autoreactive cytotoxic T lymphocytes to the skin, within then target and destroy melanocytes (Birlea et al., 2012). In European-derived whites, we have shown that vitiligo is strongly associated with two common TYR missense variants, S192Y and R402Q, which are protective (Jin et al., 2010, 2012). These protective variants are prevalent only in European-derived whites, and are not genetically associated with vitiligo in other populations, including Japanese (data not shown). Nevertheless, it seems likely that TYR functions as a major vitiligo autoimmune antigen in all populations, presented by HLA-A*02:01 in at least European-derived whites and Japanese.

Supplementary Material

Supp AppendixS1-S2

Acknowledgments

Supported by grants AR056292, AR45584, and AR057212 from the U.S. National Institutes of Health.

Footnotes

Conflict of interests

The authors state no competing financial interests.

References

  1. Birlea SA, Spritz RA, Norris DA. Vitiligo. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. McGraw-Hill; New York: 2012. [Google Scholar]
  2. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 2006;38:1166–1172. doi: 10.1038/ng1885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor. Popul. Biol. 2001;60:155–166. doi: 10.1006/tpbi.2001.1542. [DOI] [PubMed] [Google Scholar]
  4. Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N. Engl. J. Med. 2010;362:1686–1697. doi: 10.1056/NEJMoa0908547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jin Y, Ferrara T, Gowan K, et al. DNA re-sequencing identifies common variants of TYR (tyrosinase) and HLA-A that together modulate risk of generalized vitiligo via antigenic presentation. J. Invest. Dermatol. 2012;132:1730–1733. doi: 10.1038/jid.2012.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Narita T, Oiso N, Fukai K, et al. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int. 2011;60:505–508. doi: 10.2332/allergolint.11-OA-0303. [DOI] [PubMed] [Google Scholar]
  7. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006;38:904–909. doi: 10.1038/ng1847. [DOI] [PubMed] [Google Scholar]
  8. Spritz RA. Modern vitiligo genetics sheds new light on an ancient disease. J. Dermatol. 2013;40:310–318. doi: 10.1111/1346-8138.12147. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp AppendixS1-S2

RESOURCES